iRadimed
IRMD
58 hedge funds and large institutions have $25.3M invested in iRadimed in 2016 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 14 reducing their positions, and 15 closing their positions.
57% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 14
21.28% more ownership
Funds ownership: 0% → 21.28% (+21%)
6% less funds holding
Funds holding: 62 → 58 (-4)
27% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 15
43% less capital invested
Capital invested by funds: $44M → $25.3M (-$18.7M)
Top Buyers
Top Sellers
IRMD Hedge Fund Activity: Q4 2016 in Review
58 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q4 2016, worth a combined $25.3M — down 43% from $44M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of IRMD and 11 opened new positions — a net loss of 4 holders — while 14 trimmed existing stakes and 22 added.
The largest buyer was Granite Investment Partners, opening a new position worth an estimated $1.31M. The largest seller was JFS Wealth Advisors, exiting entirely with an estimated $3.23M sold.
- 58 institutional investors held iRadimed (IRMD) as of Q4 2016, down from 62 in Q3 2016.
- Funds reported $25.3M of iRadimed stock for Q4 2016, down 43% quarter-over-quarter.
- 11 funds opened new iRadimed positions in Q4 2016 and 15 closed out, a net change of -4 holders.
- The largest iRadimed buyer in Q4 2016 was Granite Investment Partners, an estimated $1.31M added.
- The largest iRadimed seller in Q4 2016 was JFS Wealth Advisors, an estimated $3.23M sold.
Based on aggregated 13F filings for Q4 2016.